Published in Lancet on March 15, 2015
THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial (PARTNER) | NCT00530894
Transcatheter Aortic Valve Replacement: a Kidney's Perspective. J Renal Inj Prev (2016) 0.90
Trends in aortic valve replacement in Germany in 2015: transcatheter versus isolated surgical aortic valve repair. Clin Res Cardiol (2017) 0.90
Experimental Study and Early Clinical Application Of a Sutureless Aortic Bioprosthesis. Rev Bras Cir Cardiovasc (2015) 0.89
Predictive factors of long-term survival in the octogenarian undergoing surgical aortic valve replacement: 12-year single-centre follow-up. Heart Vessels (2016) 0.86
Prediction of Poor Outcome After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol (2016) 0.84
Transcatheter Aortic Valve Replacement in a Young Adult Patient with a Failed Homograft. Pediatr Cardiol (2016) 0.83
Aortic Stenosis: Changing Disease Concepts. J Cardiovasc Ultrasound (2015) 0.81
Transcatheter Aortic Valve Implantation With or Without Preimplantation Balloon Aortic Valvuloplasty: A Systematic Review and Meta-Analysis. J Am Heart Assoc (2016) 0.80
Calcific aortic stenosis. Nat Rev Dis Prim (2016) 0.79
Role of Echocardiography Before Transcatheter Aortic Valve Implantation (TAVI). Curr Cardiol Rep (2016) 0.77
Mild therapeutic hypothermia in patients resuscitated from out-of-hospital cardiac arrest: A meta-analysis of randomized controlled trials. Ann Card Anaesth (2016) 0.76
Conduction disturbances after transcatheter aortic valve implantation procedures - predictors and management. Postepy Kardiol Interwencyjnej (2016) 0.75
Safety and efficacy of transcatheter aortic valve replacement in intermediate risk patients sets the stage for contemporary trials in lower risk groups. Cardiovasc Diagn Ther (2016) 0.75
PARTNERs in the future of surgical aortic valve replacement. Lancet (2015) 0.75
Transcatheter Aortic Valve Implantation for Treatment of Aortic Valve Stenosis: A Health Technology Assessment. Ont Health Technol Assess Ser (2016) 0.75
Assessment, treatment, and prognostic implications of CAD in patients undergoing TAVI. Nat Rev Cardiol (2016) 0.75
Salvage Extracorporeal Membrane Oxygenation Prior to "Bridge" Transcatheter Aortic Valve Replacement. J Card Surg (2016) 0.75
Transcatheter aortic valve implantation in 2015. J Geriatr Cardiol (2016) 0.75
ACP Journal Club: transcatheter and surgical aortic valve replacement did not differ for mortality in severe aortic stenosis. Ann Intern Med (2015) 0.75
The role of cardiovascular magnetic resonance in the assessment of severe aortic stenosis and in post-procedural evaluation following transcatheter aortic valve implantation and surgical aortic valve replacement. Quant Imaging Med Surg (2016) 0.75
Transcatheter aortic valve implantation at institutions without cardiovascular surgery departments: many questions still linger before a paradigm shift. J Thorac Dis (2016) 0.75
Midregional Proadrenomedullin Improves Risk Stratification beyond Surgical Risk Scores in Patients Undergoing Transcatheter Aortic Valve Replacement. PLoS One (2015) 0.75
Valvular disease. RCTs inform on 5-year outcomes with TAVR and its use in patients at low surgical risk. Nat Rev Cardiol (2015) 0.75
Transcatheter Aortic Valve Replacement: Comprehensive Review and Present Status. Tex Heart Inst J (2017) 0.75
Percutaneous balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation: a narrative review. Open Heart (2016) 0.75
At 5 years, transcatheter aortic valve replacement had similar rates of mortality and stroke as surgical aortic valve replacement in high-risk patients. Evid Based Med (2015) 0.75
ACP Journal Club: transcatheter aortic valve replacement reduced mortality more than usual care in inoperable severe aortic stenosis. Ann Intern Med (2015) 0.75
Impact of clinical and procedural factors upon C reactive protein dynamics following transcatheter aortic valve implantation. World J Cardiol (2016) 0.75
Von Willebrand factor multimers during transcatheter aortic valve replacement-an additional clue for detecting post-procedural aortic regurgitation? J Thorac Dis (2016) 0.75
Advances in Transcatheter Aortic Valve Replacement. Methodist Debakey Cardiovasc J (2016) 0.75
Autopsy after transcatheter aortic valve implantation. Virchows Arch (2017) 0.75
Recent advances in aortic valve replacement for aortic stenosis. F1000Res (2016) 0.75
[MitraClip® for treatment of tricuspid valve insufficiency]. Herz (2017) 0.75
Evaluation of transcatheter heart valve biomaterials: Biomechanical characterization of bovine and porcine pericardium. J Mech Behav Biomed Mater (2017) 0.75
Transcatheter Aortic Valve Replacement: Outcomes, Indications, Complications, and Innovations. Curr Treat Options Cardiovasc Med (2017) 0.75
Long-Term Outcomes of Patients With Mediastinal Radiation-Associated Severe Aortic Stenosis and Subsequent Surgical Aortic Valve Replacement: A Matched Cohort Study. J Am Heart Assoc (2017) 0.75
From CoreValve to Evolut PRO: Reviewing the Journey of Self-Expanding Transcatheter Aortic Valves. Cardiol Ther (2017) 0.75
Single versus dual anti-platelet therapy post transcatheter aortic valve implantation: a meta-analysis of randomized controlled trials. J Thromb Thrombolysis (2017) 0.75
Transcatheter Tricuspid Valve-in-Valve Replacement with an Edwards Sapien 3 Valve. Tex Heart Inst J (2017) 0.75
Matching patients with the ever-expanding range of TAVI devices. Nat Rev Cardiol (2017) 0.75
Transcatheter aortic valve implantation in a cancer patient denied for surgical aortic valve replacement-a case report. Wien Klin Wochenschr (2016) 0.75
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04
Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70
Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med (2012) 6.27
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet (2016) 2.47
Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J (2014) 2.35
Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). J Am Coll Cardiol (2013) 1.79
Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J (2016) 1.57
Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial. Eur Heart J (2022) 1.39
Percutaneous paravalvular leak closure: chasing the chameleon. Eur Heart J (2016) 0.87
The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr (2015) 0.76
Practical considerations for optimizing cardiac computed tomography protocols for comprehensive acquisition prior to transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr (2016) 0.75
Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J (2017) 0.75